응고 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Coagulation Testing Market size is expected to reach USD 7.89 Billion in 2034 from USD 4.47 Billion (2025) growing at a CAGR of 6.51% during 2026-2034.

The global coagulation testing market is experiencing steady growth due to the increasing prevalence of blood-related disorders and the rising demand for accurate diagnostic testing. Coagulation tests are used to evaluate the blood's ability to clot properly and are essential for diagnosing conditions such as hemophilia, thrombosis, and liver disease. Hospitals and diagnostic laboratories rely on these tests to monitor patients undergoing anticoagulant therapy and surgical procedures.

Technological advancements in diagnostic equipment are further driving market growth. Automated coagulation analyzers and point-of-care testing devices are improving testing efficiency and delivering faster results for healthcare professionals. The growing number of surgical procedures and the increasing use of blood-thinning medications are also contributing to higher demand for coagulation testing services.

In the future, the market is expected to expand as healthcare providers focus on improving diagnostic accuracy and patient monitoring. Increasing investments in healthcare infrastructure and laboratory technologies will further support market growth. As awareness of blood disorders and preventive healthcare increases, the demand for reliable coagulation testing solutions will continue to rise globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Consumables

By Test Type

• Prothrombin Time (PT)
• Activated Partial Thromboplastin Clotting Time (APTT)
• Thrombin Time (TT)
• Activated Clotting Time (ACT)
• Others

By End-user

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Others

COMPANIES PROFILED

• F HoffmannLa Roche Ltd, Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, Universal Biosensors Inc, HemoSonics LLC, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Horiba Ltd, Agappe Diagnostics Ltd, Medtronic plc, Helena Laboratories Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COAGULATION TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COAGULATION TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Prothrombin Time (PT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Activated Partial Thromboplastin Clotting Time (APTT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Thrombin Time (TT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Activated Clotting Time (ACT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COAGULATION TESTING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COAGULATION TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL COAGULATION TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 F. Hoffmann-La Roche Ltd
  • 9.2.2 Abbott Laboratories
  • 9.2.3 Siemens Healthineers
  • 9.2.4 Sysmex Corporation
  • 9.2.5 Universal Biosensors Inc
  • 9.2.6 HemoSonics LLC
  • 9.2.7 Thermo Fisher Scientific Inc
  • 9.2.8 Randox Laboratories Ltd
  • 9.2.9 Horiba Ltd
  • 9.2.10 Agappe Diagnostics Ltd
  • 9.2.11 Medtronic Plc
  • 9.2.12 Helena Laboratories Inc